Canntab Therapeutics Limited (CTABF)

NASDAQ

$0.00

+$0.00 (0.00%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$0.00$0.01

Open $0.01

52 Week Range

$0.00$0.01

Previous Close $0.00

Market Cap3.89K

Volume2.00K

Avg Volume1.03K

P/E (TTM)-0.05

EPS (TTM)$-0.10

Dividend / YieldN/A

Dividend StreakN/A

Popular:|||||

Compare:CNGGF|CPIVF|LIFD|NRPR|RNVA

CTABF - Free Cash Flow Growth

CTABF Free Cash Flow Growth

Canntab Therapeutics Limited (CTABF) has a free cash flow growth of 41.95% as of Friday, May 29, 2026. This represents a 73.23% increase compared to its 12-month average of 24.22%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.

Period:

CTABF - Free Cash Flow Growth

41.951%

+5.515% (+15.14%)

MarketTrack.io

Key Statistics

Day Range

$0.00$0.01

Open $0.01

52 Week Range

$0.00$0.01

Previous Close $0.00

Market Cap3.89K

Volume2.00K

Avg Volume1.03K

P/E (TTM)-0.05

EPS (TTM)$-0.10

Dividend / YieldN/A

Dividend StreakN/A